References
- Vogel J, Lee A, Souza J. Maternal morbidity and preterm birth in 22 low- and middle-income countries: a secondary analysis of the WHO Global Survey dataset. BMC Pregnancy and Childbirth 2014;14:56
- Kim J, Stirling KJ, Cooper ME, et al. Sequence variants in oxytocin pathway genes and preterm birth: a candidate gene association study. BMC Med Genet 2013;14:1471–2350
- Ward RM, Beachy JC. Neonatal complications following preterm birth. BJOG 2001;20:8–16
- Anum EA, Springel EH, Shriver MD, Strauss JF. Genetic contributions to disparities in preterm birth. Pediatr Res 2009;65:1–9
- Jaffe S, Normand N, Jayaram A, et al. Unique variation in genetic selection among Black North American women and its potential influence on pregnancy outcome. Med Hypotheses 2013;81:919–22
- Romero R, Friel LA, Velez Edwards DR, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol 2010;203:361.e1–e30
- Ryckmam KK, Marijane AK, Hyagriv NS. Interaction between interleukin-1 receptor 2 and toll-like receptor 4, and cervical cytokines. J Reprod Immunol 2011;90:220–6
- Frey H, Stout M, Tuuli M, et al. Genetic variation associated with preterm birth in black women. Am J Obstet Gynecol 2013;208:S8–9
- Price SA, Bernal AL. Uterine quiescence: the role of cyclic AMP. Exp Physiol 2001;86:265–72
- Tsunoda H, Tamatani T, Oomoto Y, et al. Changes in interleukin 1 levels in human amniotic fluid with gestational ages and delivery. Microbiol Immunol 1990;34:377–85
- Baergen R, Benirschke K, Ulich TR. Cytokine expression in the placenta. The role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and parturition. Arch Pathol Lab Med 1994;118:52–5
- Heng YJ, Liong S, Permezel M, et al. The interplay of the interleukin 1 system in pregnancy and labor. Reprod Sci 2014;21:122–30
- Imseis HM, Greig PC, Livengood CH, et al. Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. J Soc Gynecol Investig 1997;4:90–4
- Bessis N, Guery L, Mantovani A, et al. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur J Immunol 2000;30:867–75
- Müller B, Peri G, Doni A, et al. High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leuk Biol 2002;72:643–9
- Vasilyev F, Silkov A, Sennikov S. Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors. Cell Mol Immunol 2014;30:43
- Bourdiec A, Calvo E, Rao CV, Akoum A. Transcriptome analysis reveals new insights into the modulation of endometrial stromal cell receptive phenotype by embryo-derived signals interleukin-1 and human chorionic gonadotropin: possible involvement in early embryo implantation. PLoS One 2013;8:e64829
- Genc MR, Onderdonk AB, Vardhana S, et al. Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth. Am J Obstet Gynecol 2004;191:1324–13